Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro

Blood

Volumn 89, Issue 10, 1997, Pages 3806-3816

  Schultze, Joachim L ^a,b   Seamon, Mark J ^a   Michalak, Sabine ^a   Gribben, John G ^a   Nadler, Lee M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 7;

ADOPTIVE TRANSFER; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0030922328     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.10.3806.3806_3806_3816     Document Type: Article

References (44)

1. Bonnefoix T, Piccinni MP, Jacob MC, Pegourie B, Sotto JJ: Limiting dilution analysis of the frequency of IL2 responsive T cells in lymph nodes involved by B-cell non-Hodgkin's lymphomas. Leuk Res 13:323, 1989
2. Bonnefoix T, Claret E, Piccinni MP, Jacob MC, Zheng X, Sotto JJ: Detection, isolation and functional studies of CD25+ T cells in lymph nodes involved by B-cell non-Hodgkin's lymphomas. Scan J Immunol 34:91, 1991
3. Bonnefoix T, Claret E, Piccinni MP, Jacob MC, Zheng XQ, Sotto JJ: Impaired clonogenic potential of CD25 positive T cells in lymph nodes involved by B cell non-Hodgkin's lymphomas. Immunol Lett 27:135, 1991
4. Jacob MC, Piccinni MP, Bonnefoix T, Sotto MF, Couderc P, Bensa JC, Sotto J: T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: Reactivity toward the malignant clone. Blood 75:1154, 1990
5. Luna-Fineman S, Lee JE, Wesley PK, Clayberger C, Krensky AM: Human cytotoxic T-lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion. Cancer 70:2181, 1992
6. Wang Q, Stanley J, Kudoh S, Myles J, Kolenko V, Yi T, Tubbs R, Bukowski R, Finke J: T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. J Immunol 155:1382, 1995
7. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD: Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 183:283, 1996
8. Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime vytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317, 1996
9. Young JW, Inaba K: Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity [comment]. J Exp Med 183:7, 1996
10. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines (see comments). J Exp Med 183:87, 1996
11. Flamand V, Sornasse T, Theielemans K, Demanet C, Bakkus M, Bazin H, Tielemans F, Leo O, Urbain J, Muriel M: Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 24:605, 1994
12. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109, 1994
13. Stevenson FK, Zhu D, King CA, Ashworth LJ, Kumar S, Hawkins RE: Idiotypic DNA vaccines against B-cell lymphoma (review). Immunol Rev 145:211, 1995
14. Van Pel A, Van der Bruggen P, Coulie PG, Brichard VG, Lethe B, Van den Eynde B, Uyttenhove C, Renauld J-C, Boon T: Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 145:229, 1995
15. Tao M-H, Levy R: Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362:755, 1993
16. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nat Med 2:52, 1996
17. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925, 1993
18. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Ann Rev Immunol 12:881, 1994
19. Faasen AE, Dalke DP, Berton MT, Warren WD, Pierce SK: CD40-CD40 ligand interactions stimulate B cell antigen processing. Eur J Immunol 25:3249, 1995
20. Schultze JS, Cardoso AA, Freeman GJ, Seamon MJ, Daley J, Pinkus GS, Gribben JG, Nadler LM: Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci USA 92:8200, 1995
21. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz JK, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
22. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo VAJ, Ke X-Y, Gray GS, Nadler LM: CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92:811, 1995
23. Matzinger P: The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185, 1991
24. Schwartzentruber DJ, Stetler-Stevenson M, Rosenberg SA, Topalian SL: Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulation. Blood 82:1204, 1993
25. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM: B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 143:2714, 1989
26. Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freedman AS, Morimoto C, Nadler LM: B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 88:6575, 1991
27. Chen L, Ashe A, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley P: Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecule CD28 and CTLA-4. Cell 71:1093, 1992
28. Chen L, Linsley PS, Hellstrom KE: Costimulation of T cells for tumor immunity. Immunol Today 14:483, 1993
29. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VAJ, Lombard LA, Gray GS, Nadler LM: Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation (see comments). Science 262:909, 1993
30. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11:191, 1993
31. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH: Constitutive expression of B7 restores immunogenicity of autologous tumor cells. Proc Natl Acad Sci USA 90:5687, 1993
32. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 15:321, 1994
33. Shi I, Bonnefoix T, Heuze-Le Vacon F, Jacob MC, Leroux D, Gressin R, Sotto MF, Chaffanjon P, Bensa JC, Sotto JJ: Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas. Br J Haematol 90:837, 1995
34. Levitsky HI, Montgomery J, Ahmadzadeh M, Staveley-O'Carroll K, Guarnieri F, Longo DL, Kwak LW: Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J Immunol 156:3858, 1996
35. Guo Y, Wu M, Chen H, Wang X, Liu G, Ma J, Sy M: Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 263:518, 1994
36. Mueller DL, Jenkins MK: Molecular mechanism underlying functional T-cell unresponsiveness. Curr Opin Immunol 7:375, 1995
37. Matsuda M, Petersson M, Lenkei R, Taupin JL, Magnusson I, Mellstedt H, Anderson P, Kiessling R: Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease, Int J Cancer 61:765, 1995
38. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P, Kiessling R: Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610, 1993
39. Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, Longo DL, Rice NR, Komschlies KL: Alterations in NF kappa B/ Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res 54:2969, 1994
40. Levey DL, Srivastava PK: T cells from late tumor-bearing mice express normal levels of p561ck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity. J Exp Med 182:1029, 1995
41. + T cells. J Immunol 149:949, 1992
42. Inge TH, Hoover SK, Susskind BM, Barrett SK, Bear HD: Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1. Cancer Res 52:1386, 1992
43. Kudoh S, Wang Q, Hidalgo OF, Rayman P, Tubbs RR, Edinger MG, Kolenko V, Panuto J, Bukowski R, Finke JH: Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas. Cancer Immunol Immunother 41:175, 1995
44. Johnson PW, Watt SM, Betts DR, Davies D, Jordan S, Norton AJ, Lister TA: Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 82:1848, 1993